Pieris Pharmaceuticals to Host First Quarter 2017 Investor Call and Corporate Update on May 11, 2017
BOSTON, MA--(Marketwired - May 01, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing its proprietary Anticalin® biotherapeutic technologies, will host a Q1 2017 Investor Call on Thursday, May 11, 2017 at 10:00 AM (EDT) …